no image available Dickens & Co. "Combining Forces: The Triple Threat Against Glioblastoma's Resilience" "A Promising Conjugation of Sulfasalazine, Temozolomide, and Radiation Therapy in Newly Diagnosed Glioblastoma Patients" Price: 26.00€